Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP222219.RAFM-QIu6egPPPf6_jz463KInuHFcNYvyN8Nk_RE86Opw130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222219.RAFM-QIu6egPPPf6_jz463KInuHFcNYvyN8Nk_RE86Opw130_provenance.
• NP328498.RAC19E6lYc8cqMHQ4fgsihV_L9ULv2llP-8mCYmwEv6C0130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328498.RAC19E6lYc8cqMHQ4fgsihV_L9ULv2llP-8mCYmwEv6C0130_provenance.
• NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_provenance.
• NP599092.RAhnLbstyh8TE7GjYPpY18WbxeaKWYw2Ex6F8ltEQl0hI130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599092.RAhnLbstyh8TE7GjYPpY18WbxeaKWYw2Ex6F8ltEQl0hI130_provenance.
• NP324903.RAGJ0BdOmITPYAgwK4rhsQuETb4XdCFA2peFefuw6xHKk130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324903.RAGJ0BdOmITPYAgwK4rhsQuETb4XdCFA2peFefuw6xHKk130_provenance.
• NP878731.RAWra_rlagZmuJpKFM8Iptt_MAFAqXP5stWc1xjgjrBZE130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878731.RAWra_rlagZmuJpKFM8Iptt_MAFAqXP5stWc1xjgjrBZE130_provenance.
• NP930481.RAuXamCyjleDt8b3Ev2R0sWR9Tmx5rO8pNHE6ewcwd8jk130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930481.RAuXamCyjleDt8b3Ev2R0sWR9Tmx5rO8pNHE6ewcwd8jk130_provenance.
• NP297909.RAQUhQczGe84LaNQ1A6PR-nqHL2cpdlcOms24oBZmBSoE130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297909.RAQUhQczGe84LaNQ1A6PR-nqHL2cpdlcOms24oBZmBSoE130_provenance.
• NP297911.RARC9JhQRxphq21kNmmsY2PKNq8e4MQcINqw5vWYfHSg8130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297911.RARC9JhQRxphq21kNmmsY2PKNq8e4MQcINqw5vWYfHSg8130_provenance.
• NP297906.RAvxPe52I4z1RcvYf9aS4XWXHOTtv_OfZX34B7OCKGbsU130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297906.RAvxPe52I4z1RcvYf9aS4XWXHOTtv_OfZX34B7OCKGbsU130_provenance.
• NP316621.RA_9SeOlBXAVXjN-roKBy7E6nLCwC8lBw7zk9A4QokfxE130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316621.RA_9SeOlBXAVXjN-roKBy7E6nLCwC8lBw7zk9A4QokfxE130_provenance.
• NP316630.RAFxZnMIJVgeL_Lltwe6cTFtWIUtsBxNAsEJUAsuK2sHE130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316630.RAFxZnMIJVgeL_Lltwe6cTFtWIUtsBxNAsEJUAsuK2sHE130_provenance.
• NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_provenance.
• NP297912.RAH6KOq2oqZ7iltdGxuqszwbDKPtfAGXDedtTK0KEZEwE130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297912.RAH6KOq2oqZ7iltdGxuqszwbDKPtfAGXDedtTK0KEZEwE130_provenance.
• NP297905.RA1cDhwVg2MMXJoxI3bT2GMMNNoh-sQ4CmB0Q-tqK91rI130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297905.RA1cDhwVg2MMXJoxI3bT2GMMNNoh-sQ4CmB0Q-tqK91rI130_provenance.
• NP297910.RA7B_awuakzyc3-bF1bT7PhyCxCCdAA2OKV8bfftwimxM130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297910.RA7B_awuakzyc3-bF1bT7PhyCxCCdAA2OKV8bfftwimxM130_provenance.
• NP930490.RAweOpP2NAyYjfurqnxFeL4DdDRjDa3DCOU7K2fleQHF8130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930490.RAweOpP2NAyYjfurqnxFeL4DdDRjDa3DCOU7K2fleQHF8130_provenance.